PALISADE BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.74 USD | +6.17% |
|
+27.93% | -12.54% |
Chart calendar Palisade Bio, Inc.
0e.QXirawdIOS2CDhFIhck4pBx6ZD8fSKf6MEfNhgVPQAw.dyDGJF97WknvWSd44Kp2x1RJCFpuPvLCVXSG4UgnI2EeIpNfYiNTZLM9KQ~9a87c10f451fc45b0536ff2891bad222
Upcoming events on Palisade Bio, Inc.
Past events on Palisade Bio, Inc.
| 16/04/2024 09:30 pm | Virtual Investor Lunch Break Conference |
| 09/04/2024 | IBD Innovate Product Development for Crohn & Colitis Conference |
| 08/04/2024 | Reverse Split: 1 of 15 |
| 27/03/2024 05:30 pm | Q4 2023 Earnings Release |
| 25/03/2024 | Extraordinary Shareholders Meeting |
| 27/01/2024 08:30 am | Crohn Colitis Congress |
| 10/11/2023 06:35 pm | Q3 2023 Earnings Release |
| 25/10/2023 11:30 pm | Ask the CEO Virtual Investor Conference |
| 11/08/2023 05:35 pm | Q2 2023 Earnings Release |
| 22/06/2023 09:00 pm | Maxim Group Virtual Healthcare Conference |
| 08/06/2023 10:30 pm | Annual General Meeting |
| 12/05/2023 05:35 pm | Q1 2023 Earnings Release |
| 23/03/2023 05:35 pm | Q4 2022 Earnings Release |
| 18/01/2023 01:30 am | Virtual Investor Conference |
| 16/11/2022 | Reverse Split: 1 of 50 |
| 14/11/2022 07:15 pm | Q3 2022 Earnings Release |
| 18/10/2022 01:45 am | American College of Surgeons Clinical Congress |
| 06/10/2022 09:30 pm | Extraordinary Shareholders Meeting |
| 04/10/2022 10:30 pm | Extraordinary Shareholders Meeting |
| 29/09/2022 09:00 pm | Ladenburg Thalmann Healthcare Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,25 0,25 0% | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -41,9 -41,2 -1.67% | -15,3 -15,4 0.82% | -13,1 -12,8 -2.3% | -12,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,6 -29,1 8.4% | -14,3 -14,1 -1.08% | -12,3 -12,2 -0.89% | -12,5 |
|
Net income Million USD | Released Forecast Spread | -26,6 -33,1 19.59% | -14,3 -14,3 0.36% | -12,3 -12,4 0.59% | -12,5 |
|
EPS USD | Released Forecast Spread | -2 145 -2 947 27.23% | -248 -321 22.87% | -27,0 -28,1 4% | -14,4 |
| Announcement Date | 17/03/22 | 22/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,25 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -4,03 -3,10 -29.97% | -3,89 -3,92 0.92% | -3,57 -3,35 -6.63% | -4,00 -3,72 -7.71% | -3,85 -3,77 -2.07% | -2,53 -3,66 30.94% | -3,61 -3,10 -16.36% | -3,78 -3,35 -12.84% | -3,15 -3,04 -3.7% | -3,16 | -3,04 | -3,10 | -3,16 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1,07 -3,11 134.48% | -4,21 -3,92 -7.16% | -2,34 -3,35 30.03% | -3,99 -3,72 -7.39% | -3,72 -3,77 1.38% | -2,34 -3,66 36.13% | -3,39 -3,10 -9.35% | -3,60 -3,35 -7.28% | -2,97 -3,04 2.38% | -3,16 | -3,04 | -3,10 | -3,16 |
|
Net income Million USD | Released Forecast Spread | 1,07 -3,11 134.48% | -4,21 -3,92 -7.16% | -2,34 -3,35 30.03% | -3,99 -3,72 -7.39% | -3,72 -3,77 1.38% | -2,34 -3,66 36.13% | -3,39 -3,10 -9.35% | -3,60 -3,35 -7.28% | -2,97 -3,04 2.38% | -3,16 | -3,04 | -3,10 | -3,16 |
|
EPS USD | Released Forecast Spread | 480 -176 372.34% | -195 -210 7.14% | -90,0 -127 29.41% | -60,0 -60,0 0% | -89,8 -36,5 -146% | -8,10 -10,9 25.52% | -7,95 -6,83 -16.48% | -7,35 -6,15 -19.51% | -3,75 -5,18 27.54% | -3,75 | -3,60 | -3,60 | -3,45 |
| Announcement Date | 17/03/22 | 13/05/22 | 15/08/22 | 14/11/22 | 22/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 26/03/24 | - | - | - | - |
| 07/05/2024 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 07/05/2024 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | BEAM THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | PHARVARIS N.V.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | IDEAYA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | SANA BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | NOVAVAX, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 10:30 am | VALNEVA: Q1 2024 Earnings Release |
| 07/05/2024 04:30 pm | IONIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Past sector events for Palisade Bio, Inc.
| 03/05/2024 01:40 am | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:35 pm | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SNCA Stock
- Calendar Palisade Bio, Inc.
